Li‐An Xu
Daiichi Sankyo (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Systemic Lupus Erythematosus Research, Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research
Most-Cited Works
- → A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis(2011)195 cited
- → Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmacokinetics(2022)5 cited
- → Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens(2023)1 cited